Mesoblast receives FDA clearance for Duchenne muscular dystrophy trial
Go back to Mesoblast receives FDA clearance for Duchenne muscular dystrophy trial| Management Of Environmental Solutions & Technology (NASDAQ: MESO) | Delayed: 13.93 -0.19 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.12 | 52 Week High | $10.89 | |||
| Open | $13.98 | 52 Week Low | $3.50 | |||
| Day High | $14.04 | P/E | N/A | |||
| Day Low | $13.80 | EPS | $0.00 | |||
| Volume | 116,369 | |||||
